insulet corp (PODD:NASDAQ GS)
Charles T. Liamos
Director of Advanced Technology and Director, Insulet Corporation
|Age||Total Calculated Compensation||This person is connected to 51 board members in 6 different organizations across 9 different industries.|
See Board Relationships
As of Fiscal Year 2013
Mr. Charles T. Liamos, also known as Charlie, serves as a Partner of MedVenture Associates. Mr. Liamos has been Director of Advanced Technology at Insulet Corporation since January 2014. Mr. Liamos served as the Chief Operating Officer of Insulet Corporation from 2010 to January 21, 2014. He joined MedVenture Associates in September 2006 as Executive Residence. He has more than 10 years of experience of finance and operations’ leadership positions and more than 11 years ...
600 Technology Park DrivePhone: 978-600-7000
Billerica, Massachusetts 01821
Board Members Memberships*
Former Chief Operating Officer, Chief Financial Officer, Principal Accounting Officer, Director, Executive Officer of TheraSense Canada, Executive Officer of TheraSense UK Limited and Executive Officer of TheraSense Sales Corp
Director of Advanced Technology and Director
The University of Vermont
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|Miles D. White||Chairman, Chief Executive Officer and Chairman of Executive Committee|
|John C. Lechleiter Ph.D.||Chairman, Chief Executive Officer and President|
Eli Lilly and Company
|Philip Bowman||Chief Executive Officer and Executive Director|
Smiths Group plc
|Christophe Weber||Chief Executive Officer, President and Representative Director|
Takeda Pharmaceutical Company Limited
|Kim D. Blickenstaff||Chief Executive Officer, President and Director|
Tandem Diabetes Care, Inc.
|$532.7K||Compensation as of Fiscal Year 2014.|